|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Publication |
Publisher: Scottish Environment Protection Agency
Creation date: July 1999
The Scottish salmon farming industry is anticipating the release onto the market of Calicide which is a new in-feed sea lice treatment. It is likely that applications for consent to use Calicide at a number of marine cage fish farm sites will be sent in to SEPA during the summer. Field trials have shown limited but acceptable environmental risks from the use of Calicide. Calicide should be authorised for use for an initial 2 year period by the normal SEPA site-specific consent process. SEPAs Fish Farming Advisory Group (FFAG) will review these standards and their application in the light of any new scientific evidence such as from post-authorisation monitoring, and developments with predictive sediment impact models. FFAG will advise licensing teams on post-authorisation monitoring requirements. Revision 1.1 of Policy 29 takes account of additional information supplied in March 1999 from long-term monitoring of the field trial at Loch Eil and also the outcome of peer review by the Water Research Centre (WRc) on the derivation of SEPA standards for teflubenzuron.
Key Words: Scotland UK Salmon Cage culture medication Calcide Teflubenzuron Policy and Regulation Sea Lice
| HOME | HELP | FEEDBACK | E-MAIL ALERTS | ARCHIVE | SEARCH | TABLE OF CONTENTS |